-
272%
500 gene and KRAS Mutation
Identification of therapeutically relevant gene mutations for Cancer -
9%
-
20%
-
60%
-
60%
-
272%
500 gene & EGFR mutation
Identification of therapeutically relevant gene mutations for Cancer -
272%
500 gene and KRAS/NRAS/BRAF Mu ...
Identification of therapeutically relevant gene mutations for Cancer500 gene and KRAS/NRAS/BRAF Mu ...
Identification of therapeutically relevant gene mutations for Cancer -
60%
-
60%
Absolute Basophil Count
Evaluate and manage treatments including certain allergic disorders, blood disorders, neoplastic disorders, and infections caused by…Absolute Basophil Count
Evaluate and manage treatments including certain allergic disorders, blood disorders, neoplastic disorders, and infections caused by…
